
Retatrutide
Triple-agonist (higher concentration)$50per research vial · USD
A higher-concentration vial of Retatrutide, a triple-agonist research peptide studied across GIP, GLP-1, and glucagon receptor pathways in metabolic models.
Available strengths
1
Certificate of Analysis
Search code: BGSR2607010574
Report date: 07/03/2026
Purity: 99.61%
View COAFor Research Use Only. Not for human or veterinary use. This product is intended strictly for in-vitro laboratory research and development and is sold to qualified researchers only.




